Dongyu Zhang1, Shailesh Advani1,2, Zhikai Zhu1,3, Le Dang1,4, Louise C Walter5,6, Dejana Braithwaite7. 1. Department of Oncology, Georgetown University School of Medicine, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, 20007, USA. 2. Social Behavioral Research Branch, National Institute of Health, National Human Genome Research Institute, Bethesda, MD, USA. 3. Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China. 4. National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, China. 5. Department of Medicine, Division of Geriatrics, University of California, San Francisco, CA, USA. 6. Department of Medicine, Division of Geriatrics, San Francisco VA Health Care System, San Francisco, CA, USA. 7. Department of Oncology, Georgetown University School of Medicine, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, 20007, USA. db1393@georgetown.edu.
Abstract
PURPOSE: We sought to examine associations of mammography utilization with comorbidities and functional limitations in older breast cancer survivors. METHODS: Female breast cancer survivors (N = 1064) identified in the 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS) who were aged ≥ 65 years were included for this study. Mammography use, major comorbidities (diabetes mellitus, myocardial infarction, coronary heart disease, stroke, chronic obstructive pulmonary disease, arthritis, chronic kidney disease, depression, and malignancy other than breast cancer), functional limitations (impairment of vision, audition, cognition, and mobility), and other covariates were measured by self-report. We used multivariable logistic regression models to calculate adjusted odds ratios (aOR) of comorbidities and functional limitations. Subgroup analyses were conducted by age (65-74 vs. ≥ 75 years) and survival time (< 10 vs. ≥ 10 years), and interactions were examined by Wald tests. RESULTS: Of the 1064 respondents, 841 (79.0%) had comorbidities, 418 (39.3%) had functional limitations, and 744 (69.9%) underwent mammography last year. Overall, the mean age was 73.8 years (SD = 5.1 years) and 91.4% were white. The multivariable model identified inverse associations with mammography use for functional limitations (≥ 2 vs. 0: aOR = 0.61, 95% CI = 0.39-0.95, p-trend = 0.09) but not comorbidities (≥ 2 vs. 0: aOR = 0.91, 95% CI = 0.61-1.35, p-trend = 0.62). The Wald test did not find any significant interaction. CONCLUSIONS: A higher burden of functional limitations, not comorbidities, is associated with a lower rate of mammography use among older breast cancer survivors. IMPLICATIONS FOR CANCER SURVIVORS: Interventions are needed to individualize surveillance mammography among older breast cancer survivors based on their health status.
PURPOSE: We sought to examine associations of mammography utilization with comorbidities and functional limitations in older breast cancer survivors. METHODS: Female breast cancer survivors (N = 1064) identified in the 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS) who were aged ≥ 65 years were included for this study. Mammography use, major comorbidities (diabetes mellitus, myocardial infarction, coronary heart disease, stroke, chronic obstructive pulmonary disease, arthritis, chronic kidney disease, depression, and malignancy other than breast cancer), functional limitations (impairment of vision, audition, cognition, and mobility), and other covariates were measured by self-report. We used multivariable logistic regression models to calculate adjusted odds ratios (aOR) of comorbidities and functional limitations. Subgroup analyses were conducted by age (65-74 vs. ≥ 75 years) and survival time (< 10 vs. ≥ 10 years), and interactions were examined by Wald tests. RESULTS: Of the 1064 respondents, 841 (79.0%) had comorbidities, 418 (39.3%) had functional limitations, and 744 (69.9%) underwent mammography last year. Overall, the mean age was 73.8 years (SD = 5.1 years) and 91.4% were white. The multivariable model identified inverse associations with mammography use for functional limitations (≥ 2 vs. 0: aOR = 0.61, 95% CI = 0.39-0.95, p-trend = 0.09) but not comorbidities (≥ 2 vs. 0: aOR = 0.91, 95% CI = 0.61-1.35, p-trend = 0.62). The Wald test did not find any significant interaction. CONCLUSIONS: A higher burden of functional limitations, not comorbidities, is associated with a lower rate of mammography use among older breast cancer survivors. IMPLICATIONS FOR CANCER SURVIVORS: Interventions are needed to individualize surveillance mammography among older breast cancer survivors based on their health status.
Entities:
Keywords:
Breast cancer survivor; Comorbidity and functional limitation; Epidemiology; Mammography
Authors: Emmett Keeler; Jack M Guralnik; Haijun Tian; Robert B Wallace; David B Reuben Journal: J Gerontol A Biol Sci Med Sci Date: 2010-04-02 Impact factor: 6.053
Authors: Jennifer L Patnaik; Tim Byers; Carolyn Diguiseppi; Thomas D Denberg; Dana Dabelea Journal: J Natl Cancer Inst Date: 2011-06-30 Impact factor: 13.506
Authors: Carolyn D Runowicz; Corinne R Leach; N Lynn Henry; Karen S Henry; Heather T Mackey; Rebecca L Cowens-Alvarado; Rachel S Cannady; Mandi L Pratt-Chapman; Stephen B Edge; Linda A Jacobs; Arti Hurria; Lawrence B Marks; Samuel J LaMonte; Ellen Warner; Gary H Lyman; Patricia A Ganz Journal: CA Cancer J Clin Date: 2015-12-07 Impact factor: 508.702
Authors: Margarethe Wacker; Rolf Holle; Joachim Heinrich; Karl-Heinz Ladwig; Annette Peters; Reiner Leidl; Petra Menn Journal: BMC Health Serv Res Date: 2013-07-17 Impact factor: 2.655
Authors: Dongyu Zhang; Linn Abraham; Brian L Sprague; Tracy Onega; Shailesh Advani; Joshua Demb; Diana L Miglioretti; Louise M Henderson; Karen J Wernli; Louise C Walter; Karla Kerlikowske; John T Schousboe; Elizabeth Chrischilles; Dejana Braithwaite; Ellen S O'Meara Journal: Prev Med Date: 2021-11-09 Impact factor: 4.018
Authors: Sydney E Kim; Alexandra E Bachorik; Kimberly A Bertrand; Christine M Gunn Journal: J Womens Health (Larchmt) Date: 2021-12-17 Impact factor: 3.017
Authors: Dongyu Zhang; Linn Abraham; Joshua Demb; Diana L Miglioretti; Shailesh Advani; Brian L Sprague; Louise M Henderson; Tracy Onega; Karen J Wernli; Louise C Walter; Karla Kerlikowske; John T Schousboe; Ellen S O'Meara; Dejana Braithwaite Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-06-02 Impact factor: 4.254